✦ LIBER ✦

Bevacizumab, a humanized anti-angiogenic monoclonal antibody for the treatment of colorectal cancer

✍ Scribed by I. Krämer; H.-P. Lipp

Book ID: 108849009
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 560 KB
Volume: 32
Category: Article
ISSN: 0269-4727
DOI: 10.1111/j.1365-2710.2007.00800.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A humanized Anti-c-erbB-2 monoclonal ant

A humanized Anti-c-erbB-2 monoclonal antibody for the treatment of breast cancer

✍ Yutaka Tokuda; Akira Okumura; Masatoshi Ohta; Mitsuhiro Kubota; Yasuyuki Ohnishi 📂 Article 📅 1997 🏛 Springer Japan 🌐 English ⚖ 302 KB

Monoclonal antibody treatment of colorec

Monoclonal antibody treatment of colorectal cancer

✍ A. M. PULLYBLANK; J. R. T. MONSON 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Cetuximab, a chimeric human mouse anti-e

Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer

✍ Galizia, G; Lieto, E; De Vita, F; Orditura, M; Castellano, P; Troiani, T; Impera 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 129 KB

Anti-VEGF antibody bevacizumab (Avastin)

Anti-VEGF antibody bevacizumab (Avastin) with 5FU/LV as third line treatment for colorectal cancer

✍ C. Emmanouilides; M. Pegram; R. Robinson; R. Hecht; F. Kabbinavar; W. Isacoff 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 63 KB

Biodistribution of humanized anti-VEGF m

Biodistribution of humanized anti-VEGF monoclonal antibody/bevacizumab on peritoneal metastatic models with subcutaneous xenograft of gastric cancer in mice

✍ Yasumichi Yagi; Sachio Fushida; Shinichi Harada; Tomoya Tsukada; Jun Kinoshita; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 501 KB

Clinical outcome of colorectal cancer pa

Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibody

✍ Gavin W. L. Denton; Lindy G. Durrant; Jack D. Hardcastle; Eric B. Austin; Herb F 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 600 KB

## Abstract A human monoclonal anti‐idiotypic antibody (105AD7) has been developed which mimics a colorectal‐tumour‐associated antigen and induces cellular anti‐colorectal tumour immune responses in animals. Thirteen patients with advanced colorectal cancer were immunized with 105AD7 and their surv